LIFE FORWARD (Class 99)

The trademark application number 5833389 is currently marked as "Objected" in the official trademark registry.

The trademark application number 5833389 is owned by Boehringer Ingelheim International GmbH.

Trademark application number 5833389 is filed under Class 99, which relates to the specified goods and services.

Trademark application number 5833389 relates to "[CLASS : 1] Chemicals for use in industry and science; biochemical and biological preparations for use in industry and science. [CLASS : 3] Cosmetics for animals; animal grooming preparations. [CLASS : 5] Pharmaceutical preparations; stem-cells for medical purposes; biological tissue cultures for medical purposes; antibodies; vaccines; dietary supplements and dietetic preparations; veterinary preparations; stem-cells for veterinary purposes; biological tissue cultures for veterinary purposes; veterinary vaccines; antiparasitics; dietary supplements and dietetic preparations for veterinary use. [CLASS : 9] Computer software; mobile applications; downloadable software as a medical device. [CLASS : 10] Surgical, medical, dental apparatus and instruments; veterinary apparatus and instruments; inhalation devices; injectors for medical purposes. [CLASS : 31] Foodstuffs for animals. [CLASS : 41] Educational services; publishing of books, journals and other publication on communication media in the medical, veterinary and pharmaceutical fields; arranging and conducting of congresses and seminars and organizations of exhibitions in the medical, veterinary and pharmaceutical field. [CLASS : 42] Medical, veterinary, pharmacological, biological and scientific research; conducting clinical trials; computer programming in the medical and veterinary field; design and development of computer software for use with medical technology. [CLASS : 44] Veterinary services, medical services, including provided online via the internet; providing medical, veterinary, and pharmaceutical information to physicians, doctors and other health care professional as well as to patients.".